Rui Avelar - Chief Medical Officer and Head of R&D at Evolus, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer and Head of R&D
Issuer Symbol
EOLS on Nasdaq
All Insider Reports
All Insider Reports

Rui Avelar - trading volume in the past year for Evolus, Inc.

Holdings reported by Rui Avelar for Evolus, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 451,734 $2,267,704 $5.02 17 Feb 2026 Direct
Performance Restricted Stock Units 94,913 $258,015 $10.85 17 Feb 2026 Direct Common Stock
Stock Option (Right to Buy) 138,649 17 Feb 2026 Direct Common Stock

Transactions reported by Rui Avelar for Evolus, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.